Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
With the growing incidence of NAFLD on a global scale, management pathways and pharmacologic treatment options are eagerly awaited. Metabolic derangement in NAFLD associated with obesity is a key driver of disease progression and could be a useful target for pharmacologic intervention. Although NAFL...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
W B SAUNDERS CO-ELSEVIER INC
2023
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/38312/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universiti Malaya |
| Summary: | With the growing incidence of NAFLD on a global scale, management pathways and pharmacologic treatment options are eagerly awaited. Metabolic derangement in NAFLD associated with obesity is a key driver of disease progression and could be a useful target for pharmacologic intervention. Although NAFLD is more prevalent among individuals with obesity, an increasing prevalence among lean individuals has also been reported. |
|---|